A multi-state operator (MSO) of cannabis assets in the US has closed a key pending acquisition target, adding 53 stores to its portfolio.

Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) has been working on its deal for Cura Partners, the owner of the Select brand, for quite some time, as the acquisition was originally unveiled in May 2019.


CEO Joseph Lusardi said the transaction offers the company “an unprecedented phase of growth.”

So far, 2020 has been a solid year of returns for Curaleaf shareholders, as over a year-to-date period the company is up nearly 18 percent in value. However, as of 12:18 p.m. EST on Monday (February 3), the firm was down 0.64 percent, resulting in a price per share of US$9.33.

stock chart for Curaleaf

This transaction for the company faced a rocky road to completion given an unexpected level of scrutiny from antitrust regulators in the marijuana space. In 2019, several MSO deals were put on hold due to the regulations around the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) and potential second requests from the US Department of Justice (DOJ).

Originally, the Cura Partners transaction was valued at US$875 million. This changed in October, when the MSO told investors it would be adjusting the original agreement and reducing the total offer as a result of devaluations seen in the cannabis market throughout 2019.

This change in valuation was completed as part of the overall transaction, and it was able to clear the waiting period attached to the HSR review.

Most recently, in January, Curaleaf indicated it was working to complete a license transfer in Oregon related to the overall closure of the acquisition.

During an October investor event, Curaleaf Chairman Boris Jordan indicated that the DOJ was using this review process as way to “get an education on the sector.” Charlie Bachtell, CEO of fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF), echoed that sentiment in an investor call. Cresco similarly faced federal roadblocks for its now-completed acquisition of Origin House.

Alongside the assets acquired, Curaleaf confirmed to investors it will also appoint new roles as part of the deal. Jason White from Select will become the first chief marketing officer for Curaleaf.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less